Literature DB >> 34313109

NIR-Triggered Blasting Nanovesicles for Targeted Multimodal Image-Guided Synergistic Cancer Photothermal and Chemotherapy.

Zeyu Xiao1,2, Yuanyuan You1,2, Yiyong Liu1,2, Lizhen He1,2, Dong Zhang1,2, Qingqing Cheng1,2, Dan Wang1,2, Tianfeng Chen1,2, Changzheng Shi1,2, Liangping Luo1,2.   

Abstract

Escorting therapeutics for malignancies by nano-encapsulation to ameliorate treatment effects and mitigate side effects has been pursued in precision medicine. However, the majority of drug delivery systems suffer from uncontrollable drug release kinetics and thus lead to unsatisfactory triggered-release efficiency along with severe side effects. Herein, we developed a unique nanovesicle delivery system that shows near-infrared (NIR) light-triggered drug release behavior and minimal premature drug release. By co-encapsulation of superparamagnetic iron oxide (SPIO) nanoparticles, the ultrasound contrast agent perfluorohexane (PFH), and cisplatin in a silicate-polyaniline vesicle, we achieved the controllable release of cisplatin in a thermal-responsive manner. Specifically, vaporization of PFH triggered by the heat generated from NIR irradiation imparts high inner vesicle pressure on the nanovesicles, leading to pressure-induced nanovesicle collapse and subsequent cisplatin release. Moreover, the multimodal imaging capability can track tumor engagement of the nanovesicles and assess their therapeutic effects. Due to its precise inherent NIR-triggered drug release, our system shows excellent tumor eradication efficacy and biocompatibility in vivo, empowering it with great prospects for future clinical translation.

Entities:  

Keywords:  cancer chemotherapy; drug delivery; multimodal imaging; photothermal therapy; precise nanomedicine

Year:  2021        PMID: 34313109     DOI: 10.1021/acsami.1c08339

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  3 in total

1.  A multifunctional nanotheranostic agent potentiates erlotinib to EGFR wild-type non-small cell lung cancer.

Authors:  Duo Wang; Jun Zhou; Weimin Fang; Cuiqing Huang; Zerong Chen; Meng Fan; Ming-Rong Zhang; Zeyu Xiao; Kuan Hu; Liangping Luo
Journal:  Bioact Mater       Date:  2021-11-04

Review 2.  Research Progress and Prospects for Polymeric Nanovesicles in Anticancer Drug Delivery.

Authors:  Dan Li; Xi Zhang; Xiao Chen; Wei Li
Journal:  Front Bioeng Biotechnol       Date:  2022-02-11

Review 3.  Near-infrared light-triggered nano-prodrug for cancer gas therapy.

Authors:  Runcong Liu; Yongjun Peng; Ligong Lu; Shaojun Peng; Tianfeng Chen; Meixiao Zhan
Journal:  J Nanobiotechnology       Date:  2021-12-23       Impact factor: 10.435

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.